Cognition Therapeutics, Inc.
CGTX
$1.20
$0.021.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.49M | -27.99M | -32.99M | -33.30M | -33.97M |
| Total Depreciation and Amortization | 228.00K | 238.00K | 247.00K | 253.00K | 266.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.13M | 2.26M | 2.64M | 3.16M | 3.94M |
| Change in Net Operating Assets | -3.46M | -4.05M | -624.00K | -1.22M | 1.29M |
| Cash from Operations | -24.59M | -29.53M | -30.73M | -31.11M | -28.47M |
| Capital Expenditure | -- | -1.00K | -1.00K | -4.00K | -4.00K |
| Sale of Property, Plant, and Equipment | 9.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 9.00K | -1.00K | -1.00K | -4.00K | -4.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -353.00K | -474.00K | -618.00K | -679.00K | -739.00K |
| Issuance of Common Stock | 39.33M | 49.24M | 15.24M | 15.76M | 26.58M |
| Repurchase of Common Stock | -164.00K | -87.00K | -866.00K | -883.00K | -943.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.25M | -1.33M | 0.00 | -1.33M | -1.33M |
| Cash from Financing | 36.57M | 47.35M | 13.76M | 12.87M | 23.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.99M | 17.81M | -16.98M | -18.24M | -4.91M |